GSIAR: gene-subcategory interaction-based improved deep representation learning for breast cancer subcategorical analysis using gene expression, applicable for precision medicine.

Data-driven analysis Dual phase deep learning Proteome (PAM50) genetic analysis Regularized representation learning Subcategory driven analysis

Journal

Medical & biological engineering & computing
ISSN: 1741-0444
Titre abrégé: Med Biol Eng Comput
Pays: United States
ID NLM: 7704869

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 25 11 2018
accepted: 20 08 2019
pubmed: 9 10 2019
medline: 9 4 2020
entrez: 9 10 2019
Statut: ppublish

Résumé

Tumor subclass detection and diagnosis is inevitable requirement for personalized medical treatment and refinement of the effects that the somatic cells show towards other clinical conditions. The genome of these somatic cells exhibits mutations and genetic variations of the breast cancer cells and helps in understanding the characteristic behavior of the cancer cells. But their analysis is limited to clustering and there is requirement to analyze what else can be done with the data for identifying the tumor subcategory and the stages of subclasses. In this work, we have extended the work with similar data (consisting of 105 breast tumor cell lines) to solve other detection and characterization problems through computation and intelligent representation learning. Most of our work comprises of systematic data cleaning, analysis, and building prediction models with deep computational architectures and establish that the transformed data can help in better distinction of the respective categories. Our main contribution is the novel gene-subcategory interaction-based regularization (GSIAR) based data selection and analysis concept, alongside the prediction, proven to enhance the performance of the classification techniques. Graphical Abstract A graphical abstract of our model - Gene-subcategory interaction affinity-based regularization (GSIAR).

Identifiants

pubmed: 31591679
doi: 10.1007/s11517-019-02038-2
pii: 10.1007/s11517-019-02038-2
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2483-2515

Références

Lancet. 2017 Jun 17;389(10087):2430-2442
pubmed: 27939063
Cancer Res. 2005 Aug 15;65(16):7065-70
pubmed: 16103053
Lancet. 2003 Aug 2;362(9381):362-9
pubmed: 12907009
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10393-8
pubmed: 12917485
Breast Cancer Res Treat. 2017 Feb;162(1):191-198
pubmed: 28062977
Nature. 2005 Jul 28;436(7050):518-24
pubmed: 16049480
Nature. 2016 May 25;534(7605):55-62
pubmed: 27251275
Breast Cancer Res. 2010;12(4):207
pubmed: 20804570
BMC Cancer. 2019 Jan 8;19(1):41
pubmed: 30621641
Oncogene. 2019 Apr;38(15):2675-2689
pubmed: 30538297
Stat Med. 2004 Apr 15;23(7):1111-30
pubmed: 15057881
Nat Rev Clin Oncol. 2017 Oct;14(10):595-610
pubmed: 28561071
J Clin Oncol. 2006 Aug 10;24(23):3726-34
pubmed: 16720680
J Cancer. 2017 Sep 12;8(16):3131-3141
pubmed: 29158785
BMC Cancer. 2019 Apr 8;19(1):333
pubmed: 30961553
Lancet. 2011 Nov 19;378(9805):1812-23
pubmed: 22098854
Clin Cancer Res. 2005 Jul 15;11(14):5175-80
pubmed: 16033833
Clin Cancer Res. 2017 Jun 1;23(11):2702-2712
pubmed: 28151718
IEEE Trans Med Imaging. 2005 Mar;24(3):371-80
pubmed: 15754987
Cancer Res. 2017 May 1;77(9):2213-2221
pubmed: 28249905
J Clin Oncol. 2010 Apr 10;28(11):1829-34
pubmed: 20212256
J Clin Oncol. 2003 May 15;21(10):1973-9
pubmed: 12743151
Eur J Cancer. 1992;28A(8-9):1415-8
pubmed: 1515262
Cancer Res. 2001 Aug 15;61(16):5979-84
pubmed: 11507038
BMC Bioinformatics. 2008 Jul 22;9:319
pubmed: 18647401
Lancet. 2005 Feb 19-25;365(9460):671-9
pubmed: 15721472
Genome Res. 2018 Feb;28(2):159-170
pubmed: 29273624
J Clin Oncol. 2009 Mar 10;27(8):1160-7
pubmed: 19204204
Br J Cancer. 2018 Apr;118(8):1107-1114
pubmed: 29559730
Ann Oncol. 2012 Sep;23 Suppl 10:x207-10
pubmed: 22987963
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11462-7
pubmed: 11562467
Nature. 1995 Dec 21-28;378(6559):789-92
pubmed: 8524414
Anal Quant Cytol Histol. 1995 Apr;17(2):77-87
pubmed: 7612134
Breast Cancer Res. 2011 Jun 27;13(3):212
pubmed: 21787441
Mol Syst Biol. 2007;3:140
pubmed: 17940530
Cancer Cell. 2019 Jan 14;35(1):17-32.e6
pubmed: 30645973
Health Expect. 2019 Feb;22(1):74-82
pubmed: 30387238
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7077-7082
pubmed: 28630300
J Clin Oncol. 2005 Oct 10;23(29):7350-60
pubmed: 16145060
J Pathol. 2010 Jan;220(2):263-80
pubmed: 19927298
Clin Cancer Res. 2019 May 1;25(9):2848-2859
pubmed: 30718355
N Engl J Med. 2002 Dec 19;347(25):1999-2009
pubmed: 12490681
Lancet. 2003 May 10;361(9369):1590-6
pubmed: 12747878
J Pathol. 2008 Oct;216(2):141-50
pubmed: 18720457
Radiology. 1995 Sep;196(3):817-22
pubmed: 7644649
Appl Bioinformatics. 2003;2(3 Suppl):S75-83
pubmed: 15130820

Auteurs

Chiranjib Sur (C)

Computer & Information Science & Engineering Department, University of Florida, Gainesville, FL, USA. chiranjib@ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH